Dr. Hemang Baxi Cardiologist in Ahmedabad

Dr. Hemang Baxi

Cardiologist, Ahmedabad

MBBS, MD, DM

  • 1 Hospital

About

Dr. Hemang Baxi is a consultant Cardiologist associated with CIMS Hospital, Ahmedabad.

Experience

Director & Interventional Cardiologist, CIMS Hospital, Ahmedabad - Currently working here

Specialities

  • Cardiology

  • Interventional Cardiology

Procedures

  • Angioplasty

Expertise

Education

MBBS, 1992

MD (Gen. Medicine), 1995

DM (Cardiology), 1998

Practice Information

Marengo CIMS Hospital, Ahmedabad

Marengo CIMS Hospital, Ahmedabad

Off Science City Road, Near Shukan Mall, Sola, Ahmedabad, Gujarat - 380060

Achievements & Contributions

  • Clinical Research Accomplished:Effect of Folate treatment on Homocysteinemia in cardiac patients: A Prospective Study
  • Pharmacoepidemiology and Risk factors of Hypertension in Gujarat.
  • Reversal of slow or no- reflow During Percutaneous Transluminal Coronary Angioplasty Using Boluses of Intracoronary Adenosine and Sodium Nitroprusside in combination
  • Acute Results of Intermediate – term follow up of Percutaneous Transluminal Coronary Angioplasty with Cardioprotection by Balloon Occlusion Distal Protection Device
  • Effect of Tirofiban HCl in Patients with Acute Coronary Syndrome and its comparison with other GPIIb/IIIa antagonists such as Abciximab and Eptifibatide
  • Revascularization Utilizing Balloon Protection in Acute Coronary ischemic Syndrome- An International Registry
  • An International Registry of CYPHER TM-Sirolimus eluting stent
  • High prevalence of Renal Artery Stenosis in Hypertensive patients with Triple vessel Coronary Artery Disease
  • Effects of Combination of Statins and Fenofibrates with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention
  • Effect of Pioglitazone and its combination with Statins in Coronary Artery Disease patients with Hsyperinsulinemia
  • Comparison of Drug eluting stent with S7 stent
  • Assessment of Risk factors for Coronary Artery Disease
  • Effect of Niacin treatment on hyperlipoproteinemia in Coronary Artery Disease patients
  • Beneficial effects of Distal Protection Device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions
  • Comparison of Total Procedural time involved in Primary PCI with or without the use of Distal Balloon Protection system in Thrombotic Coronary lesions. (RAPID trial- Revascularization in Acute myocardial infarction using Percusurge In Distal protection)
  • Gold medal in Doctorate of Medicine (DM)
  • Left main coronary artery disease in Gujarati population. Dr. Sameer Dani, Dr. Anish Chandarana, Dr. Jayesh Rawal, Dr. Bhupesh Shah, Dr. Urmil Shah, Dr. Sharad Jain, Dr. Hemang Baxi, Dr. Hasit Joshi.
  • Pulmonary Stenosis: Long term results of balloon dilatation. Dr. Sameer Dani, Dr. Jayesh Rawal, Dr. Bhupesh Shah, Dr. Sharad Jain, Dr. Urmil Shah, Dr. Hemang Baxi, Dr. Anish Chandarana, Dr. Hasit Joshi
  • Combination of plain PTCA with stenting in coronary artery disease: immediate and intermediate-term outcome. Dr. S. I. Dani, Dr. B.R. Shah, Dr. U.G. Shah, Dr. H. Baxi, Dr. A. Chandarana, Dr. H. Joshi.
  • Intracoronary Saint Come stents: Short and mid-term follow up results. Dr. B.R. Shah, Dr. S.I. Dani, Dr. U.G. Shah, Dr. S. R. Jain, Dr. A. Chandarana, Dr. H. Baxi.
  • Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik AM, Goyal R.K. Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study: Indian J Pharmacol. (Abstract)
  • Parikh K.H., Chag M.C, Shah U.G, Baxi H.A., Chandarana A.H., Naik A.M, Goyal R.K., Shah K.J. Acute results and Intermediate term follow up of PCI with Cardioprotection by Balloon Occlusion Distal Protection Device. Indian Heart J. J-233, 2002; 54: 561-568.
  • Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of Folate Treatment on Pharmacological Homocysteinemia in Cardiac Research Patients: A Prospective Study. Pharmacological Research (submitted) 2003
  • Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of Folate Treatment on Homocysteinemia in Patients: A Prospective Study. Indian J Cardiol.2003; 5: 53
  • Shah K.J., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Reversal of Slow-Flow or No-Reflow in PTCA using boluses of IC Adenosine and Sodium Nitroprusside combination. Indian J Cardiol. 2003: 5: 38.
  • Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M.,Shah K.J., Goyal R.K. Reversal of Slow-Flow or No-Reflow in PTCA using Boluses of IC Adenosine and Sodium Nitroprusside. Suppl to JACC, March 19, 2003; 41 (6), Suppl A: 1101- 201
  • Shah K.J., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Prevalence of hyperhomocysteinemia in Western Indian Population with or without Coronary Artery Disease. Indian J Cardiol. (In Press)
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  • Chag M.C., Shah H. D., Parikh K.H., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Increased Lipoprotein (a) as a strong risk factor for Coronary Artery Disease and the effect of Niacin amongst Indians. European Society of Cardiology (Submitted) 2004
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. European Society of Cardiology (Submitted) 2004
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of combination of statins and fenofibrate with acute coronary syndrome undergoing Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004
  • Life Member of Cardiac Society of India
-->